Company Overview

Update
Founders:
Jerry Colca, Rolf Kletzien
Headquarters:
Kalamazoo, MI
Funding:
$32.90M
Categories:
Biotechnology

Metabolic Solutions Development develops innovative therapeutics based on a novel pharmacological method to treat type two diabetes.

Description

Update

Metabolic Solutions Development Company (www.msdrx.com), based in Kalamazoo, Mich., is developing innovative therapeutics based upon a novel pharmacological path to treat type 2 diabetes. This innovative approach seeks to improve the efficacy of treatment by freeing patients from the adverse side effects of current treatments, including edema and weight gain. The company’s scientific strategy is built on a historical understanding of insulin-sensitizers and its unique insight into the mechanism of insulin-sensitizing pharmacology. The company believes that its efforts will result in the creation of a new generation of superior, safer drug therapies to treat type 2 diabetes and other serious metabolic disorders.

Current Team (3)

Update

Funding Rounds (4) - $32.90M

Update

Investors (1)

Update

Offices/Locations (1)

Update
  • Office

    161 East Michigan Ave

    4th Floor

    Kalamazoo, MI 49007

    USA